Here’s Why Investors Liked Abbott Labs’ Q1 Earnings Results
Keith began writing for the Fool in 2012 and focuses primarily on healthcare investing topics. His background includes serving in management and consulting for the healthcare technology, health insurance, medical device, and pharmacy benefits management industries. Follow @keithspeights The stock of Abbott Laboratories (NYSE:ABT) was hammered …
News story posted on 2020-04-16T21:00:00.0000000Z
